LIVE Q&A
Please submit your questions via , and see below for what we've got queued up to start; recent Position Monitor updates will be covered.
|
Hedgeye House Call + Q&A | The Doctor is In | April 4 @ 2 PM | Position Monitor Moves (CANO, LFST, EYE, HCA), MQs Please join us on Monday, April 4 at 2 PM ET - Add to Outlook Health Care Subscribers: CLICK HERE for event details (includes video and materials link) |
THEME & TICKER UPDATES For Monday
Position Monitor | We've been more aggressive in moving ideas. We have a few names with key data updates scheduled for next week. We're especially keen to learn how ATIP and ONEM provider trackers landed for March. Hopefully, we'll have the first results by the time we go on Monday. We recently pushed LFST to the short bench and added CANO as well. We're also preparing a presentation for EYE, which we were long for much #reopen last year, but it looks like a good short here into the slowdown. After a review of key Quad 4 factors in Health Care, Keith added HCA after we reviewed the trends and pushed it to the long bench. They look to be having a good quarter.
Micro/Macro Quad Playbook | It's Quad 4 at the Macro level, but estimate momentum across Health Care has been stable to improving in recent weeks across our names. Is there a turn coming? Can we start getting long some "growthier" names or stick with the Factor Scores that work when growth slows alongside inflation? From the labor report today and recent data updates, the US Medical Economy is accelerating not just out of Omicron but finally breaking out of levels that have been suppressed by COVID for the last 2 years. Wage inflation and a tight labor market continue to be a challenge, but there are pockets that are better and others that are worse and #laborflow continues to be a big theme for us.
Q&A | Always the best part of the show: the question and answer session. We learn a lot in answering. Please feel free to send your questions in ahead of time and we'll make sure they are in the queue and asked and answered.
As always, all data is available upon request, and reach out to with any inquiries.
Thomas Tobin
Managing Director
Twitter
LinkedIn
